Gender-Biased Nuclear Medicine

Radioiodine therapy is essentially contra-indicated in patients who are known to be pregnant. Radioiodine easily crosses the placenta and the foetal thyroid begins to accumulate iodine at about 10 weeks of gestational age. If radioiodine treatment of thyroid carcinoma is to be performed, it should be delayed until after delivery. If this is done, the physician should also be aware that radioiodine is excreted in breast milk and breast-feeding should be stopped completely after a therapeutic dose. If this is not done the infant may become permanently hypothyroid or be at high risk for subsequent thyroid cancer.This session will discuss about the health concern of women exposed to radiation therapy, especially during the months of pregnancy, topics of discussion will include Gender Biases in Diseases, Pregnancy and Harmful effects of Radiation, Women with Ischemic Heart Disease, Osteoporosis, Gynecologic and Breast Oncologic Imaging, Radiation dose concerns for pregnant and lactating patients.

 

  • Gender Biases in Diseases
  • Pregnancy and Harmful Effects of Radiation
  • Women With Ischemic Heart Disease
  • Osteoporosis
  • Gynecologic and Breast Oncologic Imaging

Related Conference of Gender-Biased Nuclear Medicine

June 13-15 2016

Cancer Diagnostics Conference Expo

Italy
Dec 08-10 2016

14th World Congress on Cancer Therapy

USA
Oct 2-4 2016

Quality and Safety in Nuclear Medicine Molecular Imaging Meeting

USA
Sep 18 2015

Advances in Cancer Immunotherapy Conference

USA
Oct 26-30 2015

Breast MR Imaging Conference

USA
Nov 04-06 2015

10th Interventional Radiology Conference

UK
June 05-08 2017

Imaging in Israel

USA
Oct 31-Nov 07 2015

Nuclear Science Symposium Nuclear Imaging Conference

USA
Feb 21-23 201

3rd International Conference on Bioimaging

Italy
Oct 15-19 2016

29th Annual Congress of European Association of Nuclear Medicine

Spain
Jan 20-21 2016

4th Pediatric Oncology Conference

Belgium
March 04-06 2016

Asian Oncology Summit

Japan
March 08-10 2016

European Molecular Imaging Meeting

Netherlands
April 27-30 2016

European Congress on Head Neck Oncology

Turkey

Gender-Biased Nuclear Medicine Conference Speakers